This product is an antibody that was generated by immunizing rabbit against a peptide located near the internal domain of BACE1 (Human). It is used only in in vitro assays.
Introduction:Accumulation of the amyloid-b (Ab) plaque in the cerebral cortex is a critical event in the pathogenesis Alzheimer's disease. Ab peptide is generated by proteolytic cleavage of the b-amyloid protein precursor(APP) at b- and g-sites by two proteases. APP is first cleaved by b-secretase, producing a soluble derivative of the protein and a membrane anchored 99-amino acid carboxy-terminal fragment (C99). The C99 fragment serves as substrate for g-secretase to generate the 4 kDa amyloid-b peptide, which is deposited in the brains of all sufferers of Alzheimer's disease. The long-sought b-secretase was recently identified by several groups independently and designated beta-site APP cleaving enzyme (BACE) and aspartyl protease 2 (Asp2). bACE/Asp2 is a novel transmembrane aspartic protease and colocalizes with APP.
Conjugate:None
Applications: IHC
Host Species:Rabbit
Species Reactivity: Bat; Bovine; Dog; Gibbon; Guinea Pig; Hamster; Horse; Human; Monkey; Mouse; Pig; Rabbit; Rat
Immunogen:A peptide located near the internal domain of BACE1 (Human)
Purification:Immunoaffinity Chromatography
Format:Liquid
Concentration:1 mg/mL
Buffer:PBS, 0.1% sodium azide
Storage:Short term: 4˚C. Long term: Store at -20˚C.
BACE1 Polyclonal Antibody (NHP-AB309) Data Sheet: Detailed information. datasheet
There are currently no customer reviews or questions for BACE1 Polyclonal Antibody (NHP-AB309).
Click the button below to contact us or submit your feedback about this product.
Your research is unique, and we understand that standard products may not always fit. Our team of experts specializes in custom NHP sample collections. We can design a tailored protocol to meet your specific research requirements, including samples with unique anticoagulant types, customized volumes, or from specific disease models.